<code id='1B14ED3FEC'></code><style id='1B14ED3FEC'></style>
    • <acronym id='1B14ED3FEC'></acronym>
      <center id='1B14ED3FEC'><center id='1B14ED3FEC'><tfoot id='1B14ED3FEC'></tfoot></center><abbr id='1B14ED3FEC'><dir id='1B14ED3FEC'><tfoot id='1B14ED3FEC'></tfoot><noframes id='1B14ED3FEC'>

    • <optgroup id='1B14ED3FEC'><strike id='1B14ED3FEC'><sup id='1B14ED3FEC'></sup></strike><code id='1B14ED3FEC'></code></optgroup>
        1. <b id='1B14ED3FEC'><label id='1B14ED3FEC'><select id='1B14ED3FEC'><dt id='1B14ED3FEC'><span id='1B14ED3FEC'></span></dt></select></label></b><u id='1B14ED3FEC'></u>
          <i id='1B14ED3FEC'><strike id='1B14ED3FEC'><tt id='1B14ED3FEC'><pre id='1B14ED3FEC'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:5922
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Startup Neumora takes a novel depression drug to Phase 3
          Startup Neumora takes a novel depression drug to Phase 3

          AdobeNeumora,aprivatelyheldbiotechcompany,ismovingintothefinalphaseoftestingwithanoveltreatmentforde

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          FDA approves RSV monoclonal antibody for infants, toddlers

          SanofiTheFoodandDrugAdministrationapprovedamonoclonalantibodytoprotectinfantsandyoungchildrenfromsev